19 June 2013
Keywords: Lung cancer, Market forecasts, NSCLC, Decision Resources, Generic erosion
Article | 06 December 2011
Despite the arrival of generic competition – and ensuing sales erosion for several key agents used in the management of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 December 2011
5 December 2011
7 December 2011
© 2013 thepharmaletter.com